ArticleBMC public health2021
Determinants and levels of cervical Cancer screening uptake among women of reproductive age in South Africa: evidence from South Africa Demographic and health survey data, 2016.
Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Barriers and facilitators of cervical cancer screening among female healthcare professionals: a systematic review.BMC public health · 2026Pooled it
- Disparities in Human Papillomavirus Vaccination and Cervical Cancer Prevention and Screening Strategies: A Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2025Pooled it
- Barriers to Radiotherapy Access in Sub-Saharan Africa for Patients with Cancer: A Systematic Review.International journal of environmental research and public health · 2024Pooled it
- Turnaround Time Trends in Cervical Cytology Screening in South Africa, 2005-2023.Diagnostic cytopathology · 2026Article
- Factors associated with cervical cancer screening in the South African demographic and health survey.Cancer causes & control : CCC · 2026Article
- Article
- Applicability of the levels of the socio-ecological model in the context of cervical cancer prevention: a scoping review.Cancer causes & control : CCC · 2026Article
- Article
- Awareness, Cultural Beliefs, and Health-Seeking Behavior of Females in Cancer Screening: A Pilot Study in Rural South Africa.Epidemiologia (Basel, Switzerland) · 2025Article
- Determinants of cervical cancer screening uptake in Lesotho: evidence from 2024 Demographic and Health Survey data.BMC public health · 2025Article
- Understanding Cervical Cancer Screening Attendance: Barriers and Facilitators in a Representative Population Survey.Cancers · 2025Article
- High burden of abnormal cervical smears in South African primary health care: health programmes implications.Health promotion international · 2025Article
- Article
- Correlates of cervical cancer awareness among women aged 30-49 in five sub-Saharan African nations: Evidence from the Demographic and Health Survey (DHS)-2017-2023.PLOS global public health · 2025Article
- Cervical cancer awareness among women recently diagnosed with cervical cancer in South Africa and Zimbabwe.Ecancermedicalscience · 2025Article
- Article
- Factors associated with age at first screening for cervical cancer among adult Cape Verdean women: a cross-sectional study.BMC public health · 2024Article
- Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.BMC cancer · 2024Article
- Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.Journal of gynecologic oncology · 2024Article
- Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.BMC health services research · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundCervical cancer (CC) is the cancer with the most incidents and the leading cause of cancer mortality among women in South Africa. CC screening is one of the most cost-effective control approaches for the disease burden. This study assessed the determinants and individual-level indicators of cervical cancer screening uptake among women of reproductive age in South Africa.
methodsWe analyzed data from the 2016 South Africa Demographic Health Survey. Our analysis focused on 5903 women (15-49 years). We conducted Chi-square test for bivariate analysis, and multivariate binary logistics regression was used to analyze independent association between individual-level factors and women who have had Pap smear testing. Statistical significance was set at p < 0.05.
resultsThe mean age at cervical cancer screening uptake among women in South Africa was 40.8 years (SD 18.6, range 15-95 years). A majority of the women (39.3%) were aged 45 years and above and 54.6% of them resides in urban settlements. About 35.4% of women (n = 2098) have had a Pap smear test, with 66.5% of them who had a Pap smear test resides in Western Cape province. The proportion of women who had a Pap smear test was significantly higher among those with higher educational attainment (68.7%, p = 0.000), in the rich wealth index (50.1%, p = 0.000), and those with health insurance cover (60.3%, p = 0.000). Pap smear testing was found to be more prevalent among women aged 45
conclusionsThe prevalence of cervical cancer uptake is substantially low among women aged 15-24 years in South Africa and shows a degree of between-provinces differences. Therefore, heath educational interventions aimed at increasing the uptake of cervical cancer screening services in South Africa are critically needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.